Randall C. Schatzman - Dec 31, 2022 Form 5 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role
Chief Executive Officer, Director
Signature
/s/ William P. Quinn, Attorney-in-Fact
Stock symbol
BOLT
Transactions as of
Dec 31, 2022
Transactions value $
$7,055
Form type
5
Date filed
2/7/2023, 03:53 PM
Previous filing
Feb 23, 2022
Next filing
Feb 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BOLT Common Stock Purchase $4.1K +2.5K +87.44% $1.64 5.36K Jun 6, 2022 Direct F1
transaction BOLT Common Stock Purchase $2.95K +2.5K +46.65% $1.18 7.86K Dec 6, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired under the issuer's Employee Stock Purchase Plan.